Resurrection of 2′-5′-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication
PLOS Biology · 2023
DOI: 10.1371/journal.pbio.3002398 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2023. Verfasst von Spyros Lytras und 11 weiteren Autor:innen. Beteiligte Einrichtung: MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom. Hauptthemen laut MEDLINE: Chiroptera, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Daphne Jackson Trust.
Abstract (Originalsprache)
The prenylated form of the human 2′-5′-oligoadenylate synthetase 1 (OAS1) protein has been shown to potently inhibit the replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus responsible for the Coronavirus Disease 2019 (COVID-19) pandemic. However, the OAS1 orthologue in the horseshoe bats (superfamily Rhinolophoidea), the reservoir host of SARS-related coronaviruses (SARSr-CoVs), has lost the prenylation signal required for this antiviral activity. Herein, we used an ancestral state reconstruction approach to predict and reconstitute in vitro, the most likely OAS1 protein sequence expressed by the Rhinolophoidea common ancestor prior to its prenylation loss (RhinoCA OAS1). We exogenously expressed the ancient bat protein in vitro to show that, unlike its non-prenylated horseshoe bat descendants, RhinoCA OAS1 successfully blocks SARS-CoV-2 replication. Using protein structure predictions in combination with evolutionary hypothesis testing methods, we highlight sites under unique diversifying selection specific to OAS1’s evolution in the Rhinolophoidea. These sites are located near the RNA-binding region and the C-terminal end of the protein where the prenylation signal would have been. Our results confirm that OAS1 prenylation loss at the base of the Rhinolophoidea clade ablated the ability of OAS1 to restrict SARSr-CoV replication and that subsequent evolution of the gene in these bats likely favoured an alternative function. These findings can advance our understanding of the tightly linked association between SARSr-CoVs and horseshoe bats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
- Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
ORCID-Profile: Spyros Lytras, Sam J Wilson
Förderung
- Medical Research Council
- Daphne Jackson Trust
Zitieren
APA
Lytras, S., Wickenhagen, A., Sugrue, E., Stewart, D. G., Swingler, S., Sims, A., Jackson Ireland, H., Davies, E. L., Ludlam, E. M., Li, Z., Hughes, J., & Wilson, S. J. (2023). Resurrection of 2′-5′-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002398
Vancouver
Lytras S, Wickenhagen A, Sugrue E, Stewart DG, Swingler S, Sims A, et al. Resurrection of 2′-5′-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication. PLOS Biology. 2023. doi:10.1371/journal.pbio.3002398
BibTeX
@article{Lytras2023,
author = {Lytras, Spyros and Wickenhagen, Arthur and Sugrue, Elena and Stewart, Douglas G and Swingler, Simon and Sims, Anna and Jackson Ireland, Hollie and Davies, Emma L and Ludlam, Eliza M and Li, Zhuonan and Hughes, Joseph and Wilson, Sam J},
title = {Resurrection of 2′-5′-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication},
journal = {PLOS Biology},
year = {2023},
doi = {10.1371/journal.pbio.3002398}
}
EUVIMED